Russia and China to build a new pharmaceutical plant in the Irkutsk region
A Russian pharmaceutical company and its Chinese partner have announced the launch of a joint project. The parties have agreed to build a new plant for the production of pharmaceutical substances, which will be located in the Irkutsk region.
The total investment in this project is estimated at 13.06 billion tenge. The new enterprise will be an important step in the development of bilateral cooperation between Russia and China in the fields of medicine and high technology.
The main goal of building the plant is to provide the Russian market with its own raw materials for manufacturing medicines. This will help reduce dependence on imported components and make vital drugs more accessible to the citizens of Russia.
It is expected that the launch of production will create new jobs in the region and strengthen the industrial potential of the Irkutsk region. Construction will begin in the near future, and experts are already calling this project a significant contribution to the development of the domestic pharmaceutical industry.